NCT05211739

Brief Summary

The purpose of this clinical study is to assess the clinical performance of an investigational toric soft contact lens compared to a commercially available toric contact lens in a crossover dispense trial when worn in a daily wear modality for 30 days, each study lens type.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
19 days until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2022

Completed
1 year until next milestone

Results Posted

Study results publicly available

June 27, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

4 months

First QC Date

January 14, 2022

Results QC Date

June 5, 2023

Last Update Submit

June 26, 2023

Conditions

Keywords

Contact Lenses

Outcome Measures

Primary Outcomes (1)

  • Distance Visual Acuity (VA) With Study Lenses

    Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.

    Day 1 and Day 30, each wear period (approximately 30 days)

Study Arms (2)

LID205255 Toric, then Biofinity Toric

OTHER

Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.

Device: Lehfilcon A toric contact lensesDevice: Comfilcon A toric contact lensesDevice: CLEAR CARE

Biofinity Toric, then LID205255 Toric

OTHER

Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.

Device: Lehfilcon A toric contact lensesDevice: Comfilcon A toric contact lensesDevice: CLEAR CARE

Interventions

FDA-cleared silicone hydrogel toric contact lenses used as indicated

Also known as: LID205255 Toric
Biofinity Toric, then LID205255 ToricLID205255 Toric, then Biofinity Toric

Commercially available silicone hydrogel toric contact lenses used as indicated

Also known as: Biofinity Toric, CooperVision® Biofinity® Toric
Biofinity Toric, then LID205255 ToricLID205255 Toric, then Biofinity Toric

Hydrogen peroxide-based contact lens cleaning and disinfecting solution

Biofinity Toric, then LID205255 ToricLID205255 Toric, then Biofinity Toric

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Successful wearers of weekly/monthly toric soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months;
  • Best corrected distance visual acuity (as determined by manifest refraction at screening) better than or equal to 20/25 Snellen in each eye.
  • Able to wear contact lenses within the range of available sphere \& cylinder power and axes.

You may not qualify if:

  • Daily disposable contact lens wearers.
  • Monovision and multifocal contact lens wearers.
  • Habitual Biofinity Toric/Biofinity Toric XR contact lens wearers in the past 3 months prior to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Sabal Eye Care

Longwood, Florida, 32779, United States

Location

Drs. Giedd, P.A.

Maitland, Florida, 32751, United States

Location

Vision Health Institute

Orlando, Florida, 32803, United States

Location

Kannarr Eye Care LLC

Pittsburg, Kansas, 66762, United States

Location

Fischer Laser Eye Center

Willmar, Minnesota, 56201, United States

Location

SUNY College of Optometry Clinical Vision Research Center

New York, New York, 10036, United States

Location

West Bay Eye Associates

Warwick, Rhode Island, 02888, United States

Location

MeSH Terms

Conditions

Refractive ErrorsAstigmatism

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Clinical Project Lead, CRD Vision Care
Organization
Alcon Research, LLC

Study Officials

  • Clinical Trial Lead, CRD Vision Care

    Alcon Research, LLC

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2022

First Posted

January 27, 2022

Study Start

February 15, 2022

Primary Completion

June 23, 2022

Study Completion

June 23, 2022

Last Updated

June 27, 2023

Results First Posted

June 27, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations